pembrolizumab
merck
['keytruda']
keytruda combo could be effective for patients with aggressive cervical cancer - regardless of their pd-l1 expression, says new data being presented at #asco2023. potentially opens the door for immunotherapy drug to help wider ranger of patients 
The trusted source for information on cancer built in collaboration with millions of patients and the country's leading academic medical centers.